Tempest Therapeutics, Inc. (TPST) Shareholders’ equity 2013–2017
Tempest Therapeutics, Inc. (TPST) shareholders’ equity at each fiscal year-end, per SEC filings.
-$130.7MFY2017 · since FY2013: $41.7M → -$130.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -$130.7M | -220.8% |
| FY2016 | $108.2M | -14.7% |
| FY2015 | $126.8M | +129.3% |
| FY2014 | $55.3M | +32.7% |
| FY2013 | $41.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice